And what is the status of this drug? Trials have been completed; there are no side effects and no approval from the FDA is needed.
NOVOGEN (NRT.AX) is in discussions with interested parties to bring this NV07a compound to the world. This will be a mega market with no limits. Shareholders expect large returns from this compound. Indications are that some time next year, the selected partners will have been chosen and the royalties defined.
Gerry Stolwyk Disclaimer: Outcomes may be different than projected. Readers are not asked to buy, hold or sell NRT. To do so will be entirely at their own risk.m
NOVOGEN or NRT has other potential drugs in the pipeline. See the Information Post: http://www.ozestock.com.au/messageview.asp?symbol=NRT&PostNum=1833&POSTNUMBER=true
There is also an Appendix: http://www.ozestock.com.au/messageview.asp?symbol=NRT&PostNum=1832&POSTNUMBER=true
Items 10.3 and 12 of this Appendix are worth reading!
NRT Price at posting:
0.0¢ Sentiment: None Disclosure: Held